Tech Company Financing Transactions
Citius Pharmaceuticals Funding Round
On 5/5/2026, Citius Pharmaceuticals secured $36.5 million in investment from Avenue Capital.
Transaction Overview
Company Name
Announced On
5/5/2026
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$36,500,000
Round
Undisclosed
Investors
Avenue Capital (Chad Norman)
Proceeds Purpose
The Company intends to use the net proceeds from the financings primarily to fund ongoing LYMPHIR commercialization efforts such as sales force expansion, market access initiatives, medical affairs activities, and manufacturing supply chain support, with the remainder to be used for working capital and general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11 Commerce Dr. 1st Floor
Cranford, NJ 07016
USA
Cranford, NJ 07016
USA
Phone
Website
Email Address
Overview
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Myron Holubiak
Chief Executive Officer
Leonard Mazur
Chief Financial Officer
Jaime Bartushak
Chief Medical Officer
Myron Czuczman
Vice President
Ilanit Allen
Vice President
John Westman
VP - Bus. Development
Paul Sowyrda
VP - Bus. Development
Jay Wadekar
VP - Manufacturing
Kelly Creighton
VP - Operations
Gary Talarico
VP - Regulatory Affairs
Alan Lader
Browse more venture capital transactions:
Prev: 5/5/2026: Troilus Mining venture capital transaction
Next: 5/5/2026: Altara venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs